Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
Top Cited Papers
- 1 September 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 360 (9338), 971-977
- https://doi.org/10.1016/s0140-6736(02)11079-8
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Estimating HIV incidence rates from age prevalence data in epidemic situationsStatistics in Medicine, 2001
- Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workersAIDS, 2000
- A Controlled Trial of Nonoxynol 9 Film to Reduce Male-to-Female Transmission of Sexually Transmitted DiseasesNew England Journal of Medicine, 1998
- Microbicides, Meta-Analysis, and the N-9 QuestionSexually Transmitted Diseases, 1998
- The efficacy of nonoxynol-9 from an in vitro point of viewAIDS, 1996
- Barrier contraceptive use and HIV infection among high-risk women in CameroonAIDS, 1993
- Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infectionsThe Lancet, 1992
- A Clinical Trial of Nonoxynol-9 for Preventing Gonococcal and Chlamydial InfectionsThe Journal of Infectious Diseases, 1988
- IN VITRO INACTIVATION OF HIV-1 BY CONTRACEPTIVE SPONGE CONTAINING NONOXYNOL-9The Lancet, 1988
- INACTIVATION OF HTLV-III/LAV-INFECTED CULTURES OF NORMAL HUMAN LYMPHOCYTES BY NONOXYNOL-9 IN VITROThe Lancet, 1985